A2A/D2 receptor heteromerization in a model of Parkinson's disease. focus on striatal aminoacidergic signaling

Brain Research

Volumn 1476, Issue , 2012, Pages 96-107

  Ferraro, Luca ^a   Beggiato, Sarah ^a   Tomasini, Maria Cristina ^a   Fuxe, Kjell ^b   Antonelli, Tiziana ^a   Tanganelli, Sergio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

GABA and glutamate levels; Heteromeric receptor complexes; Parkinson's disease; Receptor receptor interaction

Indexed keywords

ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID;

ARTICLE; BASAL GANGLION; GABAERGIC SYSTEM; HUMAN; LOCOMOTION; NERVE FUNCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RECEPTOR BINDING; SIGNAL TRANSDUCTION; THALAMOCORTICAL TRACT;

EID: 84866863955     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.01.032     Document Type: Review

References (109)

1. L. Agnati, K. Fuxe, I. Zini, P. Lenzi, and T. Hokfelt Aspects on receptor regulation and isoreceptor identification Med. Biol. 58 1980 182 187
2. L. Agnati, K. Fuxe, M. Zoli, C. Rondanini, and S.O. Ogren New vistas on synaptic plasticity: mosaic hypothesis on the engram Med. Biol. 60 1982 183 190
3. L.F. Agnati, K. Fuxe, F. Benfenati, and N. Battistini Neurotensin in vitro markedly reduces the affinity in subcortical limbic [3H]N- propylnorapomorphine binding sites Acta Physiol. Scand. 119 1983 459 461
4. L.F. Agnati, S. Ferré, C. Lluis, R. Franco, and K. Fuxe Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons Pharmacol. Rev. 55 2003 509 550
5. L.F. Agnati, A.O. Tarakanov, S. Ferré, K. Fuxe, and D. Guidolin Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development J. Mol. Neurosci. 26 2005 193 208
6. L.F. Agnati, D. Guidolin, G. Leo, C. Carone, S. Genedani, and K. Fuxe Receptor-receptor interactions: a novel concept in brain integration Prog. Neurobiol. 90 2010 157 175
7. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
8. G.E. Alexander, and M. Crutcher Functional architecture of basal ganglia circuits: neuronal substrates of parallel processing Trends Neurosci. 13 1990 266 271
9. T. Antonelli, K. Fuxe, L. Agnati, E. Mazzoni, S. Tanganelli, M.C. Tomasini, and L. Ferraro Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias J. Neurol. Sci. 248 2006 16 22
10. N.S. Bamford, S. Robinson, R.D. Palmiter, J.A. Joyce, C. Moore, and C.K. Meshul Dopamine modulates release from corticostriatal terminals J. Neurosci. 24 2004 9541 9552
11. G. Battaglia, C.L. Busceti, G. Molinaro, F. Biagioni, M. Storto, F. Fornai, F. Nicoletti, and V. Bruno Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice J. Neurosci. 24 2004 828 835
12. N. Breysse, C. Baunez, W. Spooren, F. Gasparini, and M. Amalric Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism J. Neurosci. 22 2002 5669 5678
13. J.M. Brundege, and T.V. Dunwiddie Role of adenosine as a modulator of synaptic activity in the central nervous system Adv. Pharmacol. 39 1997 353 391
14. R.F. Bruns, G.H. Lu, and T.A. Pugsley Characterization of the A2 adenosine receptor labeled by [3H]-NECA in rat striatal membranes Mol. Pharmacol. 29 1986 331 346
15. N. Cabello, J. Gandía, D.C. Bertarelli, M. Watanabe, C. Lluís, R. Franco, S. Ferré, R. Luján, and F. Ciruela Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells J. Neurochem. 109 2009 1497 1507
16. M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S.R. Goldberg, K. Neve, K. Fuxe, L.F. Agnati, A.S. Woods, S. Ferré, C. Lluis, M. Bouvier, and R. Franco Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer J. Biol. Chem. 278 2003 46741 46749
17. M. Carlsson, and A. Carlsson Interactions between glutamatergic and monoaminergic systems within the basal ganglia3/4implications for schizophrenia and Parkinson's disease Trends Neurosci. 13 1990 272 276
18. A.L. Carvalho, C.B. Duarte, and A.P. Carvalho Regulation of AMPA receptors by phosphorylation Neurochem. Res. 25 2000 1245 1255
19. T.N. Chase, F. Bibbiani, W. Bara-Jimenez, T. Dimitrova, and J.D. Oh-Lee Translating A2A antagonist KW6002 from animal models to Parkinsonian patients Neurology 6 2003 S107 S111
20. Y. Chern, K. King, H.L. Lai, and H.T. Lai Molecular cloning of a novel adenosine receptor gene from rat brain Biochem. Biophys. Res. Commun. 185 1992 304 309
21. G. Chevalier, and J.M. Deniau Disinhibition as a basic process in the expression of striatal functions Trends Neurosci. 13 1990 277 280
22. F. Ciruela, M. Gómez-Soler, D. Guidolin, D.O. Borroto-Escuela, L.F. Agnati, K. Fuxe, and V. Fernández-Dueñas Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain Biochim. Biophys. Acta 1808 2011 1245 1255
23. P. Correia-de-Sá, M.A. Timóteo, and J.A. Ribeiro Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm J. Neurophysiol. 76 1996 3910 3919
24. C. Corsi, A. Pinna, M. Gianfriddo, A. Melani, M. Morelli, and F. Pedata Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats Eur. J. Pharmacol. 464 2003 33 38
25. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity Science 197 1977 596 598
26. J.W. Daly, P. Butts-Lamb, and W. Padgett Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines Cell. Mol. Neurobiol. 3 1983 69 80
27. S. Dasgupta, S. Ferré, B. Kull, P.B. Hedlund, U.B. Finnman, S. Ahlberg, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells Eur. J. Pharmacol. 316 1996 325 331
28. M.R. DeLong Primate models of movement disorders of basal ganglia origin Trends Neurosci. 13 1990 281 285
29. Z. Díaz-Cabiale, M. Vivó, A. Del Arco, W.T. O'Connor, M.K. Harte, C.E. Müller, E. Martínez, P. Popoli, K. Fuxe, and S. Ferré Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors Neurosci. Lett. 324 2002 154 158
30. A.K. Dixon, L. Widdowson, and P.J. Richardson Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum J. Neurochem. 69 1997 315 321
31. M.R. Domenici, R.L. Potenza, A. Martire, R. Coccurello, A. Pèzzola, R. Reggio, M.T. Tebano, and P. Popoli Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease J. Neurosci. Res. 80 2005 646 654
32. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annu. Rev. Neurosci. 24 2001 31 55
33. S. Ferrè, and K. Fuxe Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum Brain Res. 594 1992 124 130
34. S. Ferré, G. von Euler, B. Johansson, B.B. Fredholm, and K. Fuxe Stimulation of adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes Proc. Natl. Acad. Sci. U. S. A. 88 1991 7238 7241
35. S. Ferré, P. Snaprud, and K. Fuxe Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes Eur. J. Pharmacol. 244 1993 311 315
36. S. Ferré, W.T. O'Connor, K. Fuxe, and U. Ungerstedt The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain J. Neurosci. 13 1993 5402 5406
37. S. Ferré, B.B. Fredholm, M. Morelli, P. Popoli, and K. Fuxe Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci. 20 1997 482 487
38. S. Ferrè, M. Karcz-Kubicha, and B.T. Hope Synergistic interactionbetween adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function Proc. Natl. Acad. Sci. U. S. A. 99 2002 11940 11945
39. J.S. Fink, D.R. Weaver, S.A. Rivkees, R.A. Peterfreund, A.E. Pollack, E.M. Adler, and S.M. Reppert Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum Brain Res. Mol. Brain Res. 14 1992 186 195
40. R. Franco, S. Ferré, L. Agnati, M. Torvinen, S. Gines, J. Hillion, V. Casado, P. Lledo, M. Zoli, C. Lluis, and K. Fuxe Evidence for adenosine/dopamine receptor interactions: indications for heteromerization Neuropsychopharmacology 23 2000 S50 S59
41. R. Franco, M. Canals, D. Marcellino, S. Ferré, L. Agnati, J. Mallol, V. Casadó, F. Ciruela, K. Fuxe, C. Lluis, and E.I. Canela Regulation of heptaspanning-membrane-receptor function by dimerization and clustering Trends Biochem. Sci. 28 2003 238 243
42. B.B. Fredholm Purinoceptors in the nervous system Pharmacol. Toxicol. 76 1995 228 239
43. B.B. Fredholm, G. Arslan, L. Halldner, B. Kull, G. Schulte, and W. Wasserman Structure and function of adenosine A2A signaling Prog. Neurobiol. 83 2000 263 276
44. B.B. Fredholm, A.P. Ijzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
45. B.B. Fredholm, R.A. Cunha, and P. Svenningsson Pharmacology of adenosine A2A receptors and therapeutic applications Curr. Top. Med. Chem. 3 2003 413 426
46. B.B. Fredholm, Y. Chern, R. Franco, and M. Sitkovsky Aspects of the general biology of adenosine A2A signaling Prog. Neurobiol. 83 2007 263 276
47. B.B. Fredholm, Y. Chernb, R. Franco, and M. Sitkovskyd Aspects of the general biology of receptors Biochem. Pharmacol. 58 2007 1035 1045
48. K. Fuxe, and L.F. Agnati Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses Med. Res. Rev. 5 1985 441 482
49. K. Fuxe, and U. Ungerstedt Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonist Med. Biol. 52 1974 48 54
50. K. Fuxe, L.F. Agnati, F. Benfenati, M. Cimmino, S. Algeri, T. Hokfelt, and V. Mutt Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites Acta Physiol. Scand. 113 1981 567 569
51. K. Fuxe, L.F. Agnati, F. Benfenati, M. Celani, I. Zini, M. Zoli, and V. Mutt Evidence for the existence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides J. Neural Transm. Suppl. 18 1983 165 179
52. 3H]N-propylnorapomorphine binding sites in striatal membranes Eur. J. Pharmacol. 100 1984 127 130
53. K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, M. Torvinen, B. Tinner- Staines, W. Staines, D. Rosin, A. Terasmaa, P. Popoli, G. Leo, V. Vergoni, C. Lluis, F. Ciruela, R. Franco, and S. Ferré Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease Neurology 61 2003 S19 S23
54. K. Fuxe, S. Ferré, S. Genedani, R. Franco, and L.F. Agnati Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function Physiol. Behav. 92 2007 210 217
55. K. Fuxe, D. Marcellino, S. Genedani, and L. Agnati Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease Mov. Disord. 22 2007 1990 2017
56. K. Fuxe, D. Marcellino, A. Rivera, Z. Diaz-Cabiale, M. Filip, B. Gago, D.C. Roberts, U. Langel, S. Genedani, L. Ferraro, A. de la Calle, J. Narvaez, S. Tanganelli, A. Woods, and L.F. Agnati Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology Brain Res. Rev. 58 2008 415 452
57. K. Fuxe, D. Marcellino, D.O. Borroto-Escuela, M. Guescini, V. Fernández-Dueñas, S. Tanganelli, A. Rivera, F. Ciruela, and L.F. Agnati Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders CNS Neurosci. Ther. 16 2010 18 42
58. K. Fuxe, D.O. Borroto-Escuela, D. Marcellino, W. Romero-Fernández, M. Frankowska, D. Guidolin, M. Filip, L. Ferraro, A.S. Woods, A. Tarakanov, F. Ciruela, L.F. Agnati, and S. Tanganelli GPCR heteromers and their allosteric receptor-receptor interactions Curr. Med. Chem. 19 3 2012 356 363 (8)
59. A. Galvan, and T. Wichmann Phatophisiology of Parkinsonism Clin. Neurophysiol. 119 2008 1459 1474
60. C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization Trends Neurosci. 15 1992 133 139
61. C.R. Gerfen D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
62. A.M. Graybiel, J.J. Canales, and C. Capper-Loup Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis Trends Neurosci. 23 2000 S71 S77
63. D. Hervé, M. Lévi-Strauss, I. Marey-Semper, C. Verney, J.P. Tassin, J. Glowinski, and J.A. Girault G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase J. Neurosci. 13 1993 2237 2248
64. B.D. Hettinger, A. Lee, J. Linden, and D.L. Rosin Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum J. Comp. Neurol. 431 2001 331 346
65. O. Hikosaka GABAergic output of the basal ganglia Prog. Brain Res. 160 2007 209 226
66. J. Hillion, M. Canals, M. Torvinen, V. Casado, R. Scott, A. Terasmaa, A. Hansson, S. Watson, M.E. Olah, J. Mallol, E.I. Canela, M. Zoli, L.F. Agnati, C.F. Ibanez, C. Lluis, R. Franco, S. Ferre, and K. Fuxe Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors J. Biol. Chem. 277 2002 18091 18097
67. K.A. Jacobson, P.J.M. van Galen, and M.J. Williams Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential Med. Chem. 35 1992 407 422
68. H. Jiang, V. Jackson-Lewis, U. Muthane, A. Dollison, M. Ferreira, A. Espinosa, B. Parsons, and S. Przedborski Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats Brain Res. 613 1993 347 351
69. H. Kase New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia Biosci. Biotechnol. Biochem. 65 2001 1447 1457
70. K. Koga, M. Kurokawa, M. Ochi, J. Nakamura, and Y. Kuwana Adenosine A2a receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats Eur. J. Pharmacol. 408 2000 249 255
71. B. Kull, S. Ferré, G. Arslan, P. Svenningsson, K. Fuxe, C. Owman, and B.B. Fredholm Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two adenosine receptors and their genes Naunyn Schmiedebergs Arch. Pharmacol. 362 1999 364 374
72. B. Kull, P. Svenningsson, and B.B. Fredholm Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum Mol. Pharmacol. 58 2000 771 777
73. J. Lee, G. Zipfel, and D. Choi The changing landscape of ischemic brain injury Nature 399 1999 R1 R3
74. T.N. Lerner, E.A. Horne, N. Stella, and A.C. Kreitzer Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists J. Neurosci. 30 2010 2160 2164
75. M.J. Marino, O. Valenti, and P.J. Conn Glutamate receptors and Parkinson's disease: opportunities for intervention Drugs Aging 20 2003 377 397
76. D.L. Marquardt, L.L. Walker, and S. Heinemann Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells J. Immunol. 152 1994 4508 4515
77. M. Morelli, A. Pinna, S. Fenu, A. Carta, A. Cozzolino, and G. Di Chiara Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats Synapse 18 1994 288 293
78. C. Nanoff, K.A. Jacobson, and G.L. Stiles The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis Mol. Pharmacol. 39 1991 130 135
79. J.D. Oh-Lee, K. Chartisathian, S.M. Ahmed, and T.N. Chase Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats J. Neurosci. Res. 72 2003 768 780
80. P.G. Osborne, W.T. O'Connor, O. Beck, and U. Ungerstedt Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release Brain Res. 634 1994 20 30
81. K. Ossowska, J. Konieczny, S. Wolfarth, J. Wieronska, and A. Pilc Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats Neuropharmacology 41 2001 413 420
82. R.A. Peterfreund, M. MacCollin, J. Gusella, and J.S. Fink Characterization and expression of the human A2a adenosine receptor gene J. Neurochem. 66 1996 362 368
83. P. Popoli, P. Betto, R. Reggio, and G. Ricciarello Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats Eur. J. Pharmacol. 287 1995 215 217
84. P. Popoli, R. Reggio, and A. Pèzzola Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake Neuropsychopharmacology 22 2000 522 529
85. P. Popoli, A. Pezzola, and M. Torvinen The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors Neuropsychopharmacology 25 2001 505 513
86. 2 +-sensitive adenylate cyclases Mol. Pharmacol. 13 1977 662 670
87. N. Rebola, P.M. Canas, C.R. Oliveira, and R.A. Cunha Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat Neuroscience 132 2005 893 903
88. J.A. Ribeiro, A.M. Sebastião, and A. de Mendonçaa Adenosine receptors in the nervous system: pathophysiological implications Prog. Neurobiol. 68 2003 377 392
89. R. Rimondini, S. Ferré, L. Gimenez-Llort, S.O. Ögren, and K. Fuxe Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats Eur. J. Pharmacol. 347 1998 153 158
90. R.J. Rodrigues, T.M. Alfaro, N. Rebola, C.R. Oliveira, and R.A. Cunha Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum J. Neurochem. 92 2005 433 441
91. S.T. Rouse, M.J. Marino, S.R. Bradley, H. Awad, M. Wittmann, and P.J. Conn Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders Pharmacol. Ther. 88 2000 427 435
92. S.N. Schiffmann, and J.J. Vanderhaeghen Immunocytochemical detection of GABAergic nerve cells in the human striatum and cerebellum using a gamma-aminobutyric acid antiserum Neurochem. Int. 17 1990 101 106
93. S.N. Schiffmann, and J.J. Vanderhaeghen Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons J. Neurosci. 13 1993 1080 1087
94. S. Schiffmann, O. Jacobs, and J.J. Vanderhaeghen Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study J. Neurochem. 57 1991 1062 1067
95. R.K. Schwarting, and J.P. Huston The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog. Neurobiol. 50 1996 275 331
96. M.A. Schwarzschild, L. Agnati, K. Fuxe, J.F. Chen, and M. Morelli Targeting adenosine A(2A) receptors in Parkinson's disease Trends Neurosci. 29 2006 647 654
97. Y. Smith, and R. Villalba Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains Mov. Disord. 23 2008 S534 S554
98. M.S. Starr, B.S. Starr, and S. Kaur Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease Neurosci. Biobehav. Rev. 21 1997 437 446
99. I. Strömberg, P. Popoli, C.E. Müller, S. Ferré, and K. Fuxe Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum Eur. J. Neurosci. 12 2000 4033 4037
100. P. Svenningsson, C. Le Moine, B. Kull, R. Sunahara, B. Bloch, and B.B. Fredholm Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas Neuroscience 80 1997 1171 1185
101. P. Svenningsson, L. Fourreau, B. Bloch, B.B. Fredholm, F. Gonon, and C. Le Moine Opposite tonic modulation of dopamine and adenosine on c-fos mRNA expression in striatopallidal neurons Neuroscience 89 1999 827 837
102. S.L. Swope, S.J. Moss, L.A. Raymond, and R.L. Huganir Regulation of ligand-gated ion channels by protein phosphorylation Adv. Second Messenger Phosphoprotein Res. 33 1999 49 78
103. S. Tanganelli, K. Sandager Nielsen, L. Ferraro, T. Antonelli, J. Kehr, R. Franco, S. Ferré, L.F. Agnati, K. Fuxe, and J. Scheel-Krüger Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease Parkinsonism Relat. Disord. 10 2004 273 280
104. J.A. Thorn, and S.M. Jarvis Adenosine transporters Gen. Pharmacol. 27 1996 613 620
105. A. Tozzi, A. de Iure, M. Di Filippo, M. Tantucci, C. Costa, F. Borsini, V. Ghiglieri, C. Giampà, F.R. Fusco, B. Picconi, and P. Calabresi The distinct role of medium spiny neurons and cholinergic interneurons in the D2/A2A receptor interaction in the striatum: implications for Parkinson's disease J. Neurosci. 31 2011 1850 1862
106. U. Ungerstedt Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour Acta Physiol. Scand. Suppl. 367 1971 49 68
107. S.R. Wachtel, R.J. Brooderson, and F.J. White Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat Psychopharmacology (Berl.) 109 1992 41 48
108. W. Wan, G.R. Sutherland, and J.D. Geiger Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites J. Neurochem. 55 1990 1763 1771
109. Z. Wang, L. Kai, M. Day, J. Ronesi, H.H. Yin, and J. Ding Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons Neuron 50 2006 443 452